RASGRF1 and neoplasm: Furthermore, increased activity of certain tumor suppressors such as lnk4a/Arf and PTEN as well as the RasGrf1 deficiency all increase lifespan independently of anti-tumor activity (Borrás et al., 2011; Matheu et al., 2009; Ortega-Molina et al., 2012).